Body composition and aspirin dose for colorectal adenoma prevention in a randomized clinical trial

BACKGROUND: Visceral adiposity is a risk factor for colorectal adenomas, and aspirin is an established chemopreventive agent. Evidence from clinical trials suggests the effectiveness of aspirin at preventing cardiovascular disease and cancer may require higher doses for higher body weight. METHODS:...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Epidemiol Biomarkers Prev
Main Authors: Passarelli, Michael N., Barry, Elizabeth L., Rees, Judy R., Mott, Leila A., Ahnen, Dennis J., Baron, John A.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6608598/
https://ncbi.nlm.nih.gov/pubmed/31263057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0205
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker